as well as transplanted kidneys [8] [9] [10] . It has also been documented in the kidneys of patients receiving bone marrow transplants [6] , and in those of patients being treated with CsA for autoimmune diseases [11] [12] [13] [14] [15] . The lesion consists primarily of endothelial cell swelling, and nodular hyaline protein deposition in afferent arterioles associated with areas of smooth muscle cell (SMC) injury and necrosis [16] . However, little is known about its pathogenesis primarily due to the lack of an adequate animal model. This lesion has been reproduced in the SHR hypertensive rat given super therapeutic doses of CsA [17] , and some features of this lesion have also been observed by electron microscopy in Wistar rats given extremely high doses of CsA [18] . The arteriolopathy has also been described in rabbits receiving CsA [19] . However, a histologically distinguishable lesion resembling the CsA arteriolopathy identified in sections of human renal biopsies has not been identified to date in cyclosporine-treated normotensive rats.
Salt depletion has been shown to increase the susceptibility of rodents to the effects of CsA, and this maneuver facilitates production of interstitial fibrosis that mimics the striped interstitial fibrosis found in humans [20, 21] . In studies reported elsewhere we have provided data on interstitial cellular events as they relate to the subsequent development of fibrosis in this model [22, 23] . Here we document a model of chronic CsA nephropathy in salt depleted rats in which a prominent component is the development of an arteriolopathy that is virtually indistinguishable morphologically from the CsA arteriolopathy in humans.
Methods

Experimental design
Forty-eight adult, male Sprague-Dawley rats (Charles River, Wilmington, MA, USA), 225 to 250 g, were housed in individual cages and fed a low sodium diet (0.05% sodium, Teklad, Premier, WI, USA), with water ad libitum. After one week on a low salt diet, weight matched rats were randomly assigned to CsA administration of 15 mg/kg s.c. daily (Sandoz Research Inst., East Hanover, NJ, USA), or an equivalent dose of the vehicle, olive oil. There is focal smooth muscle cell injury of the glomerular afferent arteriole (arrow), with sparing of contiguous terminal interlobular artery (arrowhead) and sparing of efferent arteriole (double arrow). PAS stain, 470x.
Rats were pair fed and control and CsA treated rats were each Histology further divided into four groups of six rats each. Control and Renal tissue at sacrifice was fixed in methyl Carnoy's solution, experimental groups were sacrificed and renal tissue was obtained processed and embedded in paraffin, and cut into 4 a sections at days 5, 10, 26, and 35. using conventional techniques. Slides were stained with periodic procedures [26] . Controls included substitution of the primaly antibody with a irrelevant monoclonal antibody.
Electron microscopy Portions of the renal tissue specimens were fixed in 1/2 strength Karnovsky's solution and processed as previously described [26] . Thin sections were mounted on coated nickel grids, and stained with osmium followed by uranyl acetate. Sections were examined using a Phillips 410 electron microscope.
Results
Renal functional data for the animals reported in this investigation are given in the companion manuscript to this study [23] .
Of specific note, no differences in blood pressure between cyclosporine treated and control rats were identified at any time point studied. CsA treated animals developed a recognizable and widespread afferent arteriolar hyalinosis by day 10, with the most advanced lesions observed at days 26 and 35. The hyalinization was confined to the afferent arterioles and spared contiguous more proximal portions of the arterial tree, comprising interlobular and larger arteries. In many examples, the arterial tree could be followed from the interlobular arteries to the terminal afferent arterioles of individual glomeruli. Such examples permitted the demonstration that it was the afferent arteriole and not the more proximal contiguous arterial structures, nor adjacent efferent arterioles unattached to larger arteries, that were affected by the hyalinosis lesions (Figs. 1 to 3) . The normal rat glomerular hilar arteriole is composed of a thin single layer of smooth muscle cells overlying an endothelial lining (Fig. 1A) . In salt depleted animals after 10 days of cyclosporine treatment, approximately 1/5 to 1/2 of all identifiable arterioles showed swelling of some or all of the smooth muscle cells present in the histologic associated plane of section, with diffuse eosinophilic granular transformation of the cell cytoplasm ( Fig. 1 B, C) . No evidence of glomerular injury, endothelial cell damage, or extracellular matrix deposition was detectable at this time point, although there was mild cortical tubular dilatation. By days 26 and 35 after initiation of cyclosporine treatment, the arteriolar changes were more widespread, involving the majority of all identifiable arterioles. In affected vessels, the lesions more often, although not uniformly, involved all of the smooth muscle cells rather than just single cells, resulting in a circumferential appearance of the lesion (Fig. 2) . As affected smooth muscle cells became hypertrophied, the distinct granular character of the eosinophilic transformation at times became obscured. Occasionally, the hyaline proteinaceous deposits encountered in day 26 and day 35 specimens were localized between viable smooth muscle cells of the vessel media, as well as occurring as discrete nodules at the adventitial surface of the vessel media (Fig. 3) . This was indistinguishable from the pattern of cyclosporine arteriolopathy as it occurs in humans (Fig. 3E) . These lesions were also associated with focal vacuolization of vessel smooth muscle cells. In no case were subendothelial hyaline accumulations identified as a principal manifestation of arteriolopathy, and in no case was there evidence of inflammatory cell infiltration of vessel walls.
In normal animals, immunohistochemical stains for renin showed prominent circumferential expression of renin by all the SMC comprising the glomerular hilar arterioles, without evidence of expression within more proximal muscular arteries (Fig. 4A) . Immunohistochemical detection of renin in CsA treated animals showed both enhanced staining of the juxtaglomerular (JG) apparatus, as well as staining of glomerular hilar arterioles that was often similar to that seen in control animals. However, in day 35 rats, there was focal accentuation of arteriolar staining in areas appearing to correspond to hyaline deposition (Fig. 4B ). This could not be reliably ascertained due to the obscuring of underlying vessel architectural detail by the intense staining observed with the renin antibody. Most significantly, in day 35 CsA treated animals, there was proximal extension of normal arteriolar staining for renin, including distal portions of interlobular arteries in some vessels. However, this was not a uniform finding within the CsA group.
Electron microscopy of day 35 CsA treated animals demonstrated focal but dramatic changes in arterioles compared to controls. Smooth muscle cells of arterioles demonstrating focal or diffuse hyaline transformation, as detected by histologic examination of screening plastic sections, were found to contain diffuse cytoplasmic accumulations of membrane bound granules with a morphologic appearance characteristic of renin granules. In some arterioles there was diffuse transformation of all the smooth muscle cells comprising the vessel wall by this process (Fig. 5) ; in others the process involved only a subset of vascular smooth muscle cells (Fig. 6 ). These studies confirmed the discreteness of the injury to specific smooth muscle cells. Cells showing diffuse cytoplasmic transformation could be found adjacent to smooth muscle cells without any evidence of such injury. No ultrastructural abnormalities were discerned in glomeruli or arterial structures adjacent to affected arterioles. There appeared to be a morphologic transition between smooth muscle cells showing diffuse cytoplasmic accumulations of granules to cells showing lesser numbers of such granules dispersed in a finely granular, amorphous electron dense material similar to hyaline material ascribed to cellular and proteinaceous debris in the setting of human vascular injury (Fig. 7) . No examples of hyaline-like deposits without some persistence of intracytoplasmic granules were detected within the time frame of this study.
Discussion
In humans, a number of systemic disease processes can result in arteriolar hyalinosis. These include hypertension, aging and diabetes. The microvascular manifestations occurring as a result of each of these injuries demonstrate considerable morphologic overlap, and are often indistinguishable. All are characterized by predominantly subendothelial collections of nondescript hyaline material, a material thought to be composed of insudated plasma proteins. CsA associated arteriolopathy (and perhaps FK 506 arteriolopathy as well) is distinguished from these other entities by the characteristic localization of hyaline deposits within the medial layers of smooth muscle cells and at the outer surface of affected vessels [27-291. In this form of injury, subendothelial hyaline is not a characteristic feature. CsA arteriolopathy in humans also has a peculiar localization to afferent arterioles and terminal portions of interlobular arteries [27, 29, 30}. A model of cyclosporine arteriolopathy should replicate these morphologic findings as closely as possible and should be free of confounding physiologic parameters such as hypertension and hyperglycemia if at all possible.
In this report we document a model of chronic CsA nephropathy in normotensive rodents, with hyalinization of afferent arterioles that is strikingly similar to CsA-induced human arteriolopathy. The arteriolopathy appears to be widespread and progressive in the setting of continued CsA exposure. Perhaps most importantly, some morphologic features of this model closely resemble human CsA arteriolopathy by virtue of the distinct involvement of the muscular wall of the afferent arterioles as opposed to the nondescript, subendothelial accumulation of hyaline material that is nonspecifically found in other human arteriolopathies as noted above, and furthermore, by the distinct anatomic localization to afferent arterioles and not the proximal portions of the renal arterial tree. However, it must also be recognized that there may be some smooth muscle cells, obscuring the features characteristic of developing injury as we have studied it in the rat. Furthermore, there is a potential discrepancy in relating cycloporine arteriolopathy to increased arteriolar renin production in that plasma renin activity in humans treated with cyclosporine, unlike rats, is typically unchanged or even depressed compared to untreated controls [36] . However, this discrepancy may be more theoretical than real, since multiple intervening steps subsequent to renin synthesis and packaging in granules, which are not well characterized, but which include those regulating local renin secretion and activation, could have major effects on measured levels of renin activity. Salt depletion appears to be a critical factor in the development of CsA arteriolopathy in the rat, as it is in other manifestations of experimental cyclosporine induced nephropathy [20, 21, 31 ]. This conclusion is based upon the observation that the arteriolopathy has not been identified to date in non-salt depleted models of experimental cyclosporine injury in the rat. Salt depletion was originally employed to accentuate the "tubular glomerular feedback" loop [32] that contributes to increased renal vascular resistance via the renin-angiotensin system (RAS), which is based on the amount of chloride delivered to the macula densa of the distal tubule. The ensuing hypothesis predicts that salt-depletion would accelerate CsA induced disease in animals at least in part as a function of the resistance changes. Our study, in conjunction with the efforts of others who have not utilized salt depleted models, and who have not encountered noteworthy arteriolopathy, indicates CsA arteriolopathy also is accentuated in the salt-depleted rat model. This in turn implicates the renin-angiotensin system in the pathogenesis of this lesion, although other factors such as enhanced endothelin production or activity have clearly been implicated in this disease [33] [34] [35] . The morphologic correlation of smooth muscle "hyaline" injury and intracellular accumulation of renin granules detected by electron microscopy further identifies alterations in the intrarenal arteriolar renin system as an important component in the development of arteriolopathy. Finally, enhanced arteriolar accumulation of renin was detected immunocytochemically, a finding made by others as well [36] , which also points to a role for local stimulation of renin production in the development of cyclosporine arteriolopathy.
With the model presented in this study, the hypothesis that enhanced renin production and/or activity is essential to the development of CsA arteriolopathy can be tested. For example, blockade of the RAS with the angiotensin-Il receptor antagonist, Losartan [37] , and the angiotensin converting enzyme-inhibitor, enalapril [38] , reported to reduce interstitial fibrosis, can be examined as to whether or not they decrease the formation of the arteriolopathy. Another test of validity of this model would be a more extended observational study to characterize the evolution of the arteriolar hyaline lesion into a more amorphous accumulation of granular hyaline material that is suggested by the findings in some day 35 experimental animals, and that is characteristic of established human CsA arteriolopathy. A final approach would be immunohistochemical studies of human CsA arteriolopathy in its various morphologic stages that might identify renin accumulation early in the development of this lesion. Each of these studies is currently under way.
CsA arteriolopathy was at first thought to be an irreversible lesion, but now has shown to be reversible with stopping or lowering the dose of the drug [29, 30] . If validated, this model will allow a means to define therapeutic interventions that can contribute to amelioration of this form of injury.
In summary, the salt-depleted model of chronic cyclosporine nephropathy produces alterations of afferent arterioles which are similar to the lesion produced by CsA in humans. We conclude that this is a relevant model that may be used to study the long-term effects of cyclosporine nephrotoxicity.
